Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
195.21
+1.39 (0.72%)
May 22, 2026, 4:00 PM EDT - Market closed
Quest Diagnostics Stock Forecast
Stock Price Forecast
According to 18 analysts polled by S&P Global, Quest Diagnostics stock has a consensus rating of "Buy" and an average price target of $223.25. The average 1-year stock price forecast is 14.36% higher than the current stock price, while the lowest is $184 (-5.74%) and the highest is $245 (+25.51%).
Price Target: $223.25 (+14.36%)
Analyst Consensus: Buy
* Price targets were last updated on Apr 22, 2026.
Analyst Ratings
The average analyst rating for Quest Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Hold | 9 | 9 | 8 | 8 | 8 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 13 | 13 | 13 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $210 → $220 | Hold | Maintains | $210 → $220 | +12.70% | Apr 22, 2026 |
| Baird | Baird | Hold Maintains $224 → $229 | Hold | Maintains | $224 → $229 | +17.31% | Apr 22, 2026 |
| Barclays | Barclays | Buy Maintains $225 → $230 | Buy | Maintains | $225 → $230 | +17.82% | Apr 22, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $220 → $225 | Hold | Maintains | $220 → $225 | +15.26% | Apr 22, 2026 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $220 → $210 | Hold | Maintains | $220 → $210 | +7.58% | Apr 8, 2026 |
Financial Forecast
Revenue This Year
11.97B
from 11.04B
Increased by 8.47%
Revenue Next Year
12.50B
from 11.97B
Increased by 4.39%
EPS This Year
10.87
from 8.75
Increased by 24.23%
EPS Next Year
11.78
from 10.87
Increased by 8.34%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 12.5B | 13.2B | |||
| Avg | 12.0B | 12.5B | |||
| Low | 11.6B | 12.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 13.4% | 10.6% | |||
| Avg | 8.5% | 4.4% | |||
| Low | 4.7% | -0.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 11.67 | 12.92 | |||
| Avg | 10.87 | 11.78 | |||
| Low | 10.34 | 11.10 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 33.3% | 18.8% | |||
| Avg | 24.2% | 8.3% | |||
| Low | 18.2% | 2.1% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.